doxazosin

Generic: doxazosin

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-043
Product ID 71610-043_98f8771c-b6c1-4fbe-845f-876cc3cbfe75
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075580
Listing Expiration 2026-12-31
Marketing Start 2015-04-09

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610043
Hyphenated Format 71610-043

Supplemental Identifiers

RxCUI
197627
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA075580 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (71610-043-60)
source: ndc

Packages (1)

71610-043-60 90 TABLET in 1 BOTTLE (71610-043-60)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "98f8771c-b6c1-4fbe-845f-876cc3cbfe75", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-043-60)", "package_ndc": "71610-043-60", "marketing_start_date": "20180302"}], "brand_name": "Doxazosin", "product_id": "71610-043_98f8771c-b6c1-4fbe-845f-876cc3cbfe75", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-043", "generic_name": "Doxazosin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA075580", "marketing_category": "ANDA", "marketing_start_date": "20150409", "listing_expiration_date": "20261231"}